Skip to main content

Featured

Trump and Zelensky Tout Progress Toward Peace Deal Despite Major Sticking Points

   U.S. President Donald Trump and Ukrainian President Volodymyr Zelensky hold a press conference after their lunch meeting at Trump's Mar-a-Lago club. Former U.S. President Donald Trump and Ukrainian President Volodymyr Zelensky struck an optimistic tone after meeting in Florida, suggesting that negotiations toward a potential Ukraine‑Russia peace agreement are nearing completion. Trump described the talks as “very close,” while Zelensky said the two sides had aligned on the majority of key issues. The meeting followed Trump’s recent call with Russian President Vladimir Putin, which he characterized as constructive. Zelensky emphasized that the discussions were productive and that both leaders share a desire to accelerate the path toward ending the conflict. Despite the upbeat messaging, significant obstacles remain. Unresolved issues reportedly include territorial questions, long‑term security guarantees for Ukraine, and the sequencing of troop withdrawals—topics that hav...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment